VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 69 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,400 | -60.4% | 33,600 | -41.5% | 0.00% | -50.0% |
| Q2 2023 | $657,173 | +227.8% | 57,395 | +120.8% | 0.00% | +100.0% |
| Q1 2023 | $200,460 | +1.2% | 26,000 | -22.2% | 0.00% | 0.0% |
| Q2 2022 | $198,000 | -73.1% | 33,427 | -65.3% | 0.00% | -50.0% |
| Q1 2022 | $735,000 | +1212.5% | 96,457 | +616.7% | 0.00% | – |
| Q2 2021 | $56,000 | -96.4% | 13,459 | -95.9% | 0.00% | -100.0% |
| Q1 2021 | $1,540,000 | +53.5% | 326,994 | +354.8% | 0.00% | +33.3% |
| Q4 2019 | $1,003,000 | -23.3% | 71,897 | -5.3% | 0.00% | -25.0% |
| Q3 2019 | $1,307,000 | +0.9% | 75,930 | +59.5% | 0.00% | 0.0% |
| Q2 2019 | $1,295,000 | -2.0% | 47,591 | -66.1% | 0.00% | -20.0% |
| Q4 2018 | $1,321,000 | -18.3% | 140,536 | +64.4% | 0.01% | +25.0% |
| Q3 2018 | $1,617,000 | -51.6% | 85,481 | -50.0% | 0.00% | -60.0% |
| Q2 2018 | $3,338,000 | +939.9% | 170,817 | +898.9% | 0.01% | +900.0% |
| Q1 2018 | $321,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |